GENAISSANCE PHARMACEUTICALS INC Business Finance Contracts & Agreements
14 Contracts & Agreements
- Exchange Agreements (2 contracts)
- Loan Agreements (1)
- Note Agreements (1)
- Registration Rights Agreements (2)
- Security Agreements (1)
- Stock Agreements (5)
- Warrant Agreements (2)
- PLEDGEAND SECURITY AGREEMENT (Filed With SEC on April 27, 2005)
- REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on April 27, 2005)
- WARRANTNO. toPurchase Common Stock of GENAISSANCEPHARMACEUTICALS, INC. (Filed With SEC on April 27, 2005)
- SENIORSECURED NOTE (Filed With SEC on April 27, 2005)
- NOTE AND WARRANT PURCHASEAGREEMENT among GENAISSANCE PHARMACEUTICALS,INC., LARK TECHNOLOGIES, INC., the Co-Borrowers, and XMARK OPPORTUNITY FUND, L.P., XMARK OPPORTUNITY FUND,... (Filed With SEC on April 27, 2005)
- WARRANTNO. to PurchaseCommon Stock of GENAISSANCEPHARMACEUTICALS, INC. (Filed With SEC on November 22, 2004)
- GENAISSANCE PHARMACEUTICALS, INC. INCENTIVE PLAN 2000 AMENDED AND RESTATED EQUITY Incentive Stock Option Terms And Conditions (Filed With SEC on November 15, 2004)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission.Asterisks denote omissions. CONSUMER GENOMICS AND HAP TECHNOLOGYLICENSE AGREEMENT... (Filed With SEC on February 23, 2004)
- Confidential Materials omitted and filedseparately with the Securities and Exchange Commission.Asterisks denote omissions. CONSUMER GENOMICS AND HAP TECHNOLOGYLICENSE AGREEMENT... (Filed With SEC on December 2, 2003)
- GENAISSANCEPHARMACEUTICALS, INC. LOAN AND SECURITY AGREEMENT (Filed With SEC on November 14, 2003)
- WARRANT to Purchase Series A Preferred Stock of GENAISSANCE PHARMACEUTICALS, INC. (Filed With SEC on November 5, 2003)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 5, 2003)
- SERIES A PREFERRED STOCK PURCHASE AGREEMENT Dated as of October 29, 2003 by and between GENAISSANCE PHARMACEUTICALS, INC. and RAM TRADING, LTD. TABLE OF CONTENTS (Filed With SEC on November 5, 2003)
- Certificate of Designations of the Preferred Stock Of Genaissance Pharmaceuticals, Inc. To be Designated Series A Preferred Stock (Filed With SEC on November 5, 2003)